Clinical experience with ioversol 320 in cranial computed tomographic scanning

Area of Science:

• Radiology
• Medical Imaging
• Neuroradiology

Background:

• Contrast agents are essential for enhancing image quality in computed tomographic (CT) scanning.
• Ioversol 320 is a non-ionic, iodinated contrast medium used in medical imaging.
• Cerebral CT (CCT) scanning is a crucial diagnostic tool for evaluating brain conditions.

Purpose of the Study:

• To evaluate the safety, tolerance, and efficacy of ioversol 320.
• To assess the clinical outcomes of using ioversol 320 in CCT scanning.
• To determine the diagnostic value of CCT scans performed with ioversol 320.

Main Methods:

• An open-label, noncomparative study was conducted.
• Sixty patients undergoing CCT scanning were enrolled.
• The safety, tolerance, and efficacy of ioversol 320 were assessed through vital sign monitoring, adverse event reporting, and radiographic quality assessment.

Main Results:

• No drug-related, clinically significant changes in vital signs were observed.
• No serious adverse reactions or reported pain during intravenous injection occurred.
• Radiographic quality was rated excellent or good for patients with enhanceable brain lesions.
• All CCT scans were considered diagnostic.

Conclusions:

• Ioversol 320 is safe and well-tolerated for CCT scanning.
• The contrast agent demonstrated efficacy in improving radiographic quality for diagnostic CCT scans.
• Ioversol 320 is an effective option for enhancing CCT imaging.